Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Plunged Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) fell sharply on Monday, following an analyst downgrade and positive vaccine trial results from a rival drugmaker. By the close of trading, its stock price was down 12.8% after falling as much 17.7% earlier in the day.

JPMorgan cut its rating on Moderna's stock from "overweight" to "neutral," citing concerns that its valuation has become stretched after its torrid run so far in 2020. Prior to today, Moderna's shares were up a staggering 385% year to date and 576% over the past year.

Moderna's stock gave up a portion of its recent gains on Monday. Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share